Sabzevari Helen
Insider CIK 1724195 · PGEN President, Precigen, Inc., Director · KNTE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PGEN PRECIGEN, INC. | M Exercise deriv | 2026-08-23 | 2026-08-25 | 20,833 | — | $0 | 229,167 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2026-08-23 | 2026-08-25 | 20,833 | — | $0 | 3,789,705 | SEC↗ |
| PGEN PRECIGEN, INC. | F Tax w/h | 2026-08-23 | 2026-08-25 | 10,184 | $7.20 | $73.3K | 3,779,521 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2026-08-23 | 2026-08-25 | 20,833 | — | $0 | 229,167 | SEC↗ |
| PGEN PRECIGEN, INC. | F Tax w/h | 2026-08-23 | 2026-08-25 | 10,184 | $7.20 | $73.3K | 3,779,521 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2026-08-23 | 2026-08-25 | 20,833 | — | — | 3,789,705 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2026-06-29 | 2026-07-01 | 346,836 | — | $0 | 500,164 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2026-06-29 | 2026-07-01 | 346,836 | $5.89 | $2.04M | 3,768,872 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2026-06-29 | 2026-07-01 | 346,836 | $2.33 | $808.1K | 4,115,708 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2026-05-28 | 2026-06-01 | 119,250 | $4.36 | $519.9K | 3,768,872 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2026-05-23 | 2026-05-27 | 250,000 | — | $0 | 250,000 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2026-05-23 | 2026-05-27 | 250,000 | — | $0 | 3,888,122 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2026-04-20 | 2026-04-22 | 1,366,000 | — | $0 | 1,366,000 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2026-04-20 | 2026-04-22 | 410,000 | — | $0 | 410,000 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2026-03-18 | 2026-03-20 | 321,100 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2026-03-18 | 2026-03-20 | 321,100 | — | $0 | 321,100 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2026-03-18 | 2026-03-20 | 321,100 | — | $0 | 3,638,122 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2025-09-12 | 2025-09-16 | 825,000 | — | $0 | 825,000 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2025-06-26 | 2025-06-27 | 500,000 | — | $0 | 500,000 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2025-05-23 | 2025-05-27 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2025-05-16 | 2025-05-16 | 1,079,137 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2025-05-16 | 2025-05-16 | 1,079,137 | — | $0 | 3,838,246 | SEC↗ |
| PGEN PRECIGEN, INC. | F Tax w/h | 2025-05-16 | 2025-05-16 | 521,224 | $1.45 | $755.8K | 3,317,022 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2025-04-17 | 2025-04-18 | 1,079,137 | — | $0 | 1,079,137 | SEC↗ |
| PGEN PRECIGEN, INC. | F Tax w/h | 2025-01-29 | 2025-02-03 | 286,967 | $1.30 | $373.1K | 2,759,109 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award | 2025-01-29 | 2025-02-03 | 825,000 | — | $0 | 3,046,076 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2024-05-31 | 2024-05-31 | 1,803,000 | — | $0 | 1,803,000 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2024-04-05 | 2024-04-09 | 1,071,429 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2024-04-05 | 2024-04-09 | 1,071,429 | — | $0 | 1,071,429 | SEC↗ |
| PGEN PRECIGEN, INC. | F Tax w/h | 2024-04-05 | 2024-04-09 | 410,357 | $1.40 | $574.5K | 2,221,076 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2024-04-05 | 2024-04-09 | 1,071,429 | — | $0 | 2,631,433 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 40,501 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 25,000 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2023-08-25 | 2023-08-25 | 76,969 | $1.53 | $117.8K | 1,560,004 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2023-08-23 | 2023-08-25 | 141,587 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2023-08-23 | 2023-08-25 | 141,587 | — | $0 | 1,636,973 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2023-08-18 | 2023-08-18 | 55,855 | $1.66 | $92.7K | 1,495,386 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2023-08-16 | 2023-08-18 | 141,587 | — | $0 | 141,587 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2023-08-16 | 2023-08-18 | 141,587 | — | $0 | 1,551,241 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2023-08-11 | 2023-08-11 | 41,436 | $1.44 | $59.7K | 1,409,654 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2023-08-09 | 2023-08-11 | 141,587 | — | $0 | 283,173 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2023-08-09 | 2023-08-11 | 141,587 | — | $0 | 1,451,090 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2023-08-04 | 2023-08-04 | 52,870 | $1.10 | $58.2K | 1,309,503 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2023-08-02 | 2023-08-04 | 141,587 | — | $0 | 424,760 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2023-08-02 | 2023-08-04 | 141,587 | — | $0 | 1,362,373 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2023-04-28 | 2023-05-02 | 1,732,300 | — | $0 | 1,732,300 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2023-03-24 | 2023-03-28 | 849,520 | — | $0 | 849,520 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2023-03-24 | 2023-03-28 | 283,173 | — | $0 | 566,347 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2023-03-24 | 2023-03-28 | 369,596 | — | $0 | 369,596 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2023-03-24 | 2023-03-28 | 283,173 | — | $0 | 1,220,786 | SEC↗ |
| PGEN PRECIGEN, INC. | P Buy | 2023-01-27 | 2023-01-30 | 22,857 | $1.75 | $40.0K | 937,613 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2023-01-04 | 2023-01-06 | 17,665 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2023-01-04 | 2023-01-06 | 17,665 | — | $0 | 914,756 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,250 | — | $0 | 20,250 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2022-05-13 | 2022-05-16 | 177,968 | $1.19 | $211.8K | 897,091 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2022-05-12 | 2022-05-16 | 340,909 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2022-05-12 | 2022-05-16 | 340,909 | — | $0 | 1,075,059 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2022-03-18 | 2022-03-22 | 340,909 | — | $0 | 340,909 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2022-02-02 | 2022-02-04 | 847,000 | — | $0 | 847,000 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2022-01-05 | 2022-01-06 | 5,603 | $3.59 | $20.1K | 734,150 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2022-01-05 | 2022-01-06 | 1,357 | $3.59 | $4.9K | 739,753 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2022-01-04 | 2022-01-06 | 17,667 | — | $0 | 17,665 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2022-01-04 | 2022-01-06 | 17,667 | — | $0 | 741,110 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2022-01-03 | 2022-01-04 | 3,848 | $3.67 | $14.1K | 723,443 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2022-01-02 | 2022-01-04 | 9,765 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2022-01-02 | 2022-01-04 | 9,765 | — | $0 | 727,291 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2021-07-19 | 2021-07-20 | 12,531 | $5.43 | $68.0K | 717,526 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2021-07-17 | 2021-07-20 | 25,000 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2021-07-17 | 2021-07-20 | 25,000 | — | $0 | 730,057 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2021-06-24 | 2021-06-28 | 40,501 | — | $0 | 40,501 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2021-05-13 | 2021-05-14 | 47,433 | $6.40 | $303.6K | 705,057 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2021-05-12 | 2021-05-14 | 97,276 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2021-05-12 | 2021-05-14 | 97,276 | — | $0 | 752,490 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2021-03-25 | 2021-03-29 | 97,276 | — | $0 | 97,276 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2021-01-06 | 2021-01-07 | 260,045 | $8.92 | $2.32M | 655,214 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2021-01-05 | 2021-01-07 | 500,000 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2021-01-05 | 2021-01-06 | 9,040 | $10.56 | $95.5K | 415,259 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2021-01-05 | 2021-01-07 | 500,000 | — | $0 | 915,259 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2021-01-04 | 2021-01-06 | 17,667 | — | $0 | 35,332 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2021-01-04 | 2021-01-05 | 5,279 | $10.16 | $53.6K | 406,632 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2021-01-04 | 2021-01-06 | 17,667 | — | $0 | 424,299 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2021-01-02 | 2021-01-05 | 9,766 | — | $0 | 9,765 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2021-01-02 | 2021-01-05 | 9,766 | — | $0 | 411,911 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2020-07-20 | 2020-07-21 | 12,220 | $4.58 | $56.0K | 402,145 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2020-07-17 | 2020-07-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2020-07-17 | 2020-07-21 | 25,000 | — | $0 | 414,365 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2020-05-15 | 2020-05-18 | 217,527 | $2.37 | $515.5K | 389,365 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2020-05-14 | 2020-05-18 | 500,000 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2020-05-14 | 2020-05-18 | 500,000 | — | $0 | 606,892 | SEC↗ |
| PGEN PRECIGEN, INC. | S Sale | 2020-04-01 | 2020-04-02 | 5,450 | $3.01 | $16.4K | 106,892 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2020-03-31 | 2020-04-02 | 14,340 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2020-03-31 | 2020-04-02 | 14,340 | — | $0 | 112,342 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2020-03-23 | 2020-03-23 | 500,000 | — | $0 | 500,000 | SEC↗ |
| XON INTREXON CORP | S Sale | 2020-01-06 | 2020-01-07 | 6,732 | $5.83 | $39.2K | 98,002 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2020-01-05 | 2020-01-07 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2020-01-05 | 2020-01-07 | 500,000 | — | $0 | 500,000 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2020-01-05 | 2020-01-07 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2020-01-05 | 2020-01-07 | 1,500,000 | — | $0 | 1,500,000 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2020-01-04 | 2020-01-07 | 17,667 | — | $0 | 52,999 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2020-01-04 | 2020-01-07 | 17,667 | — | $0 | 104,734 | SEC↗ |
| XON INTREXON CORP | S Sale | 2020-01-03 | 2020-01-06 | 3,886 | $5.77 | $22.4K | 87,067 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2020-01-02 | 2020-01-06 | 9,766 | — | $0 | 19,531 | SEC↗ |
| XON INTREXON CORP | S Sale | 2020-01-02 | 2020-01-03 | 4,830 | $5.60 | $27.0K | 81,187 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2020-01-02 | 2020-01-06 | 9,766 | — | $0 | 90,953 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2019-12-31 | 2020-01-03 | 14,340 | — | $0 | 14,340 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2019-12-31 | 2020-01-03 | 14,340 | — | $0 | 86,017 | SEC↗ |
| XON INTREXON CORP | S Sale | 2019-10-01 | 2019-10-02 | 5,005 | $5.50 | $27.5K | 71,677 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2019-09-30 | 2019-10-02 | 14,341 | — | $0 | 28,680 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2019-09-30 | 2019-10-02 | 14,341 | — | $0 | 76,682 | SEC↗ |
| XON INTREXON CORP | S Sale | 2019-07-18 | 2019-07-19 | 8,484 | $7.47 | $63.4K | 62,341 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2019-07-17 | 2019-07-19 | 25,000 | — | $0 | 50,000 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2019-07-17 | 2019-07-19 | 25,000 | — | $0 | 70,825 | SEC↗ |
| XON INTREXON CORP | S Sale | 2019-07-01 | 2019-07-02 | 4,822 | $7.76 | $37.4K | 45,825 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2019-06-30 | 2019-07-02 | 14,341 | — | $0 | 43,021 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2019-06-30 | 2019-07-02 | 14,341 | — | $0 | 50,647 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2019-04-09 | 2019-04-11 | 57,362 | — | $0 | 57,362 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2019-01-25 | 2019-01-29 | 56,891 | — | $0 | 70,666 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2019-01-04 | 2019-01-08 | 13,775 | — | $0 | 13,775 | SEC↗ |
| XON INTREXON CORP | A Award | 2019-01-04 | 2019-01-08 | 13,774 | — | $0 | 36,306 | SEC↗ |
| XON INTREXON CORP | S Sale | 2019-01-03 | 2019-01-04 | 3,832 | $7.07 | $27.1K | 22,532 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2019-01-02 | 2019-01-04 | 9,766 | — | $0 | 29,297 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2019-01-02 | 2019-01-04 | 9,766 | — | $0 | 26,364 | SEC↗ |
| XON INTREXON CORP | S Sale | 2018-07-18 | 2018-07-19 | 8,402 | $14.54 | $122.2K | 16,598 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2018-07-17 | 2018-07-19 | 25,000 | — | $0 | 75,000 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2018-07-17 | 2018-07-19 | 25,000 | — | $0 | 25,000 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2018-03-28 | 2018-04-05 | 100,000 | — | $0 | 100,000 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2018-01-02 | 2018-01-08 | 39,063 | — | $0 | 39,063 | SEC↗ |